Lievin R, Maillard A, Hendel-Chavez H, Krzysiek R, Lancar R, Algarte-Genin M
Blood Adv. 2024; 8(23):6017-6027.
PMID: 39348664
PMC: 11635670.
DOI: 10.1182/bloodadvances.2024014116.
Hubel K, Bower M, Aurer I, Bastos-Oreiro M, Besson C, Brunnberg U
Hemasphere. 2024; 8(9):e150.
PMID: 39233903
PMC: 11369492.
DOI: 10.1002/hem3.150.
Odeny T, Fink V, Muchengeti M, Gopal S
Infect Dis Clin North Am. 2024; 38(3):531-557.
PMID: 39111924
PMC: 11529824.
DOI: 10.1016/j.idc.2024.06.007.
Arya S, Shahid Z
Front Oncol. 2024; 14:1398078.
PMID: 39026972
PMC: 11255439.
DOI: 10.3389/fonc.2024.1398078.
Urak R, Pahlavanneshan S, Gittins B, Nakamura R, Zaia J, Baird J
Haematologica. 2024; 109(9):3053-3058.
PMID: 38779743
PMC: 11367234.
DOI: 10.3324/haematol.2024.285321.
CD20 CAR T cells safely and reversibly ablate B cell follicles in a non-human primate model of HIV persistence.
Bui J, Starke C, Poole N, Rust B, Jerome K, Kiem H
Mol Ther. 2024; 32(5):1238-1251.
PMID: 38414244
PMC: 11081808.
DOI: 10.1016/j.ymthe.2024.02.030.
Toxicity Profile of Chimeric Antigen Receptor T-Cell and Bispecific Antibody Therapies in Multiple Myeloma: Pathogenesis, Prevention and Management.
Markouli M, Ullah F, Unlu S, Omar N, Lopetegui-Lia N, Duco M
Curr Oncol. 2023; 30(7):6330-6352.
PMID: 37504327
PMC: 10378049.
DOI: 10.3390/curroncol30070467.
Integrated genetic analyses of immunodeficiency-associated Epstein-Barr virus- (EBV) positive primary CNS lymphomas.
Kaulen L, Denisova E, Hinz F, Hai L, Friedel D, Henegariu O
Acta Neuropathol. 2023; 146(3):499-514.
PMID: 37495858
PMC: 10412493.
DOI: 10.1007/s00401-023-02613-w.
Site-specific transgene integration in chimeric antigen receptor (CAR) T cell therapies.
Dabiri H, Safarzadeh Kozani P, Habibi Anbouhi M, Mirzaee Godarzee M, Haddadi M, Basiri M
Biomark Res. 2023; 11(1):67.
PMID: 37403182
PMC: 10318782.
DOI: 10.1186/s40364-023-00509-1.
Diffuse Large B-Cell Lymphoma in the HIV Setting.
Huguet M, Navarro J, Molto J, Ribera J, Tapia G
Cancers (Basel). 2023; 15(12).
PMID: 37370801
PMC: 10296551.
DOI: 10.3390/cancers15123191.
The role of viruses in HIV-associated lymphomas.
Lurain K, Ramaswami R, Yarchoan R
Semin Hematol. 2023; 59(4):183-191.
PMID: 36805886
PMC: 9971650.
DOI: 10.1053/j.seminhematol.2022.11.002.
Is CD19-directed chimeric antigen receptor T cell therapy a smart strategy to combat central nervous system lymphoma?.
Miyao K, Yokota H, Sakemura R
Front Oncol. 2023; 12:1082235.
PMID: 36686821
PMC: 9850100.
DOI: 10.3389/fonc.2022.1082235.
In vivo killing of primary HIV-infected cells by peripheral-injected early memory-enriched anti-HIV duoCAR T cells.
Anthony-Gonda K, Ray A, Su H, Wang Y, Xiong Y, Lee D
JCI Insight. 2022; 7(21).
PMID: 36345941
PMC: 9675454.
DOI: 10.1172/jci.insight.161698.
The Fingerprints of Biomedical Science in Internal Medicine.
Arjmand B, Alavi-Moghadam S, Sarvari M, Tayanloo-Beik A, Aghayan H, Mehrdad N
Adv Exp Med Biol. 2022; 1401:173-189.
PMID: 35856133
DOI: 10.1007/5584_2022_729.
Real-World Experiences of CAR T-Cell Therapy for Large B-Cell Lymphoma: How Similar Are They to the Prospective Studies?.
Tang K, Nastoupil L
J Immunother Precis Oncol. 2022; 4(3):150-159.
PMID: 35663108
PMC: 9138439.
DOI: 10.36401/JIPO-21-2.
HIV-Associated Lymphomas: Progress and New Challenges.
Pongas G, Ramos J
J Clin Med. 2022; 11(5).
PMID: 35268547
PMC: 8911067.
DOI: 10.3390/jcm11051447.
Cytomegalovirus Retinitis and Retinal Detachment following Chimeric Antigen Receptor T Cell Therapy for Relapsed/Refractory Multiple Myeloma.
Zu C, Xu Y, Wang Y, Zhang M, Zhao H, Fang X
Curr Oncol. 2022; 29(2):490-496.
PMID: 35200544
PMC: 8870699.
DOI: 10.3390/curroncol29020044.
Primary Effusion Lymphoma: A Clinicopathologic Perspective.
Gathers D, Galloway E, Kelemen K, Rosenthal A, Gibson S, Munoz J
Cancers (Basel). 2022; 14(3).
PMID: 35158997
PMC: 8833393.
DOI: 10.3390/cancers14030722.
Progress in the Treatment of HIV-Associated Lymphoma When Combined With the Antiretroviral Therapies.
Wang C, Liu J, Liu Y
Front Oncol. 2022; 11:798008.
PMID: 35096597
PMC: 8792758.
DOI: 10.3389/fonc.2021.798008.
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of lymphoma.
Neelapu S, Adkins S, Ansell S, Brody J, Cairo M, Friedberg J
J Immunother Cancer. 2020; 8(2).
PMID: 33361336
PMC: 7768967.
DOI: 10.1136/jitc-2020-001235.
